FDA Approves First Therapy to Reduce Pancreatitis Risk - Quiz - MDSpire

FDA Approves First Therapy to Reduce Pancreatitis Risk

In two placebo-controlled trials, triglyceride levels declined by up to 72% compared with placebo.

  • By

  • Kathryn Wighton

  • June 24, 2026

  • 2 min

Share

Original Source(s)

FDA Approves First Therapy to Reduce Pancreatitis Risk

  • by Kathryn Wighton

  • June 24, 2026

Related Content

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

Shorter DAPT Tested Following CABG

TOP-CABG compared 3 months vs 12 months of ticagrelor plus aspirin following bypass surgery.

Medical Oddities: The Economics of Shut-Eye

Sleep became a commodity, tea became a therapy, and cats got a reprieve this week.